Biotech
Startup wants to grow “headless humans” to replace lab animals
Researchers describe brainless, lab-grown human bodies engineered to host full organ systems and study disease without consciousness.
Israeli mathematician uses AI to decode human immune system
Israel's overlooked challenge: Environmental damage from two years of war - from the editor
Immunai, Bristol Myers Squibb sign AI immune-data collaboration
EU regulator backs two Omicron-adapted COVID boosters
Developed by Moderna and the team of Pfizer and BioNTech, the new so-called bivalent shots combat the BA.1 version of Omicron and the original virus first detected in China.
How do you make it to the top? Three female leaders give their best advice
What are three mottos you should swear by, according to three of the biggest biotechnological leaders in Israel?
CRISPR gene editing may cause permanent damage - study
Caution from researchers at Tel Aviv University: CRISPR gene editing can damage the genome and might trigger cancer.
Precise Bio partners with ZEISS to develop bio-printed cornea implants
These bio-printed eye tissues would be used for transplants to treat vision correction and corneal diseases such as keratoconus.
BioGenCell raises $16m. for chronic disease treatment
The company’s treatment has already prevented loss of limb in several patients during Phase I trials.
AI bio-tech company Nucleai raises $33M, brings in new executives
Nuclei aims to use the funds to further its efforts to transform drug development and clinical treatments.
Israeli Biotech company says it can revolutionize drug development
Tissue Dynamics Ltd., an Israeli biotechnology company, says it can cut drug development cost by 40% to 80% and the time required by 30% to 50%.
‘Cell-based, innovative products for a better future’
Pluristem’s proprietary cell-based technology platform develops cutting-edge therapies and cultured food materials
Reimagining the future of food
Israel’s northern Galilee has become the new go-to destination for food-tech start-ups
3D bioprinting tech to be licensed by Tel Aviv University
The technology was used to print a heart made of human cells and extracellular matrix at TAU in 2019.
